Azstarys in Ora-Blend Single Dose

This new central nervous system stimulant may be used to treat attention-deficit/hyperactivity disorder in patients aged 6 years and older.

COVID-19 News Digest

Clinical developments related to coronavirus of interest to pharmacists.

New Drug Review 2021

Highlighting newly approved medications that treat attention-deficit/hyperactivity disorder, homozygous familial hypercholesterolemia, and HIV type 1 infection, and an agent for preventing pregnancy.

Managing Atopic Dermatitis in Children

The mainstay of treatment is topical agents, but more severe cases may require additional therapies.

Addressing Barriers to Emergency-Contraceptive Access

Obstacles such as state regulations, antitheft boxes, and misinformation prevent patients from obtaining emergency contraceptives in a timely manner.

Review of Selected NMEs 2021

Spotlighting new molecular entities that target COVID-19, severe hypoglycemia, metastatic non–small cell lung cancer, large B-cell lymphoma, and metastatic HER2-positive breast cancer.

Watch New
Pharmacist Recommendation Series here

Take Quiz

Continuing Education

$6.97 Per CE Exam or $59 for 12 Lessons

Quick Poll

Are Your Patients Using Opioids for Migraine Headache?